As of 2025-07-01, the Relative Valuation of Phathom Pharmaceuticals Inc (PHAT) is (88.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.59 USD, the upside of Phathom Pharmaceuticals Inc based on Relative Valuation is -1025.8%.
The range of the Relative Valuation is (85.99) - (88.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 17.9x | 17.4x |
| Forward P/E multiples | 17.4x - 20.0x | 18.4x |
| Fair Price | (85.99) - (88.66) | (88.79) |
| Upside | -996.7% - -1024.5% | -1025.8% |
| Date | P/E |
| 2025-06-27 | -1.97 |
| 2025-06-26 | -1.93 |
| 2025-06-25 | -1.93 |
| 2025-06-24 | -1.97 |
| 2025-06-23 | -1.91 |
| 2025-06-20 | -2.10 |
| 2025-06-18 | -2.20 |
| 2025-06-17 | -2.12 |
| 2025-06-16 | -2.15 |
| 2025-06-13 | -2.15 |
| 2025-06-12 | -2.02 |
| 2025-06-11 | -1.83 |
| 2025-06-10 | -1.81 |
| 2025-06-09 | -1.78 |
| 2025-06-06 | -1.80 |
| 2025-06-05 | -0.95 |
| 2025-06-04 | -0.95 |
| 2025-06-03 | -1.00 |
| 2025-06-02 | -0.94 |
| 2025-05-30 | -0.86 |
| 2025-05-29 | -0.87 |
| 2025-05-28 | -0.82 |
| 2025-05-27 | -0.83 |
| 2025-05-23 | -0.81 |
| 2025-05-22 | -0.85 |
| 2025-05-21 | -0.79 |
| 2025-05-20 | -0.88 |
| 2025-05-19 | -0.89 |
| 2025-05-16 | -0.82 |
| 2025-05-15 | -0.70 |
| 2025-05-14 | -0.66 |
| 2025-05-13 | -0.67 |
| 2025-05-12 | -0.64 |
| 2025-05-09 | -0.63 |
| 2025-05-08 | -0.46 |
| 2025-05-07 | -0.48 |
| 2025-05-06 | -0.48 |
| 2025-05-05 | -0.52 |
| 2025-05-02 | -0.56 |
| 2025-05-01 | -0.68 |
| 2025-04-30 | -0.87 |
| 2025-04-29 | -0.88 |
| 2025-04-28 | -0.84 |
| 2025-04-25 | -0.83 |
| 2025-04-24 | -0.83 |
| 2025-04-23 | -0.81 |
| 2025-04-22 | -0.80 |
| 2025-04-21 | -0.79 |
| 2025-04-17 | -0.81 |
| 2025-04-16 | -0.85 |